"When switching dosage forms, if the prescriber does not obtain the desired therapeutic endpoint in spite of education about the extensive differences in inhalers, there are alternatives - use of a spacer, increased dose causing more side effects or switching to Xopenex, the R- enantiomer which is the active portion of the racemic albuterol."